JP2002543193A - プロゲステロン受容体モジュレーターとしてのシクロカルバメート誘導体 - Google Patents

プロゲステロン受容体モジュレーターとしてのシクロカルバメート誘導体

Info

Publication number
JP2002543193A
JP2002543193A JP2000615601A JP2000615601A JP2002543193A JP 2002543193 A JP2002543193 A JP 2002543193A JP 2000615601 A JP2000615601 A JP 2000615601A JP 2000615601 A JP2000615601 A JP 2000615601A JP 2002543193 A JP2002543193 A JP 2002543193A
Authority
JP
Japan
Prior art keywords
substituted
alkyl
dihydro
dimethyl
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000615601A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002543193A5 (zh
Inventor
ツアング，プエン
テレフエンコ，ユージン・エイ
フレツチヤー，ホーレース，ザサード
フエンサム，アンドリユー
ブローベル，ジエイ・イー
ジ，リン
ジヨーンズ，トツド・ケイ
テグリー，クリストフアー・エム
エドワーズ，ジエイムズ・ピー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of JP2002543193A publication Critical patent/JP2002543193A/ja
Publication of JP2002543193A5 publication Critical patent/JP2002543193A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2000615601A 1999-05-04 2000-05-01 プロゲステロン受容体モジュレーターとしてのシクロカルバメート誘導体 Pending JP2002543193A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US60/183,012 1999-05-04
US09/552,633 2000-04-19
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (2)

Publication Number Publication Date
JP2002543193A true JP2002543193A (ja) 2002-12-17
JP2002543193A5 JP2002543193A5 (zh) 2007-06-28

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000615601A Pending JP2002543193A (ja) 1999-05-04 2000-05-01 プロゲステロン受容体モジュレーターとしてのシクロカルバメート誘導体

Country Status (19)

Country Link
EP (1) EP1173426A1 (zh)
JP (1) JP2002543193A (zh)
KR (1) KR20010114250A (zh)
CN (1) CN1145618C (zh)
AU (1) AU766428B2 (zh)
BG (1) BG106079A (zh)
BR (1) BR0010213A (zh)
CA (1) CA2371726A1 (zh)
CZ (1) CZ20013951A3 (zh)
EA (1) EA004512B1 (zh)
HU (1) HUP0201609A3 (zh)
IL (1) IL146280A0 (zh)
MX (1) MXPA01011286A (zh)
NO (1) NO321361B1 (zh)
NZ (1) NZ515355A (zh)
PL (1) PL351127A1 (zh)
SG (1) SG114650A1 (zh)
SK (1) SK15912001A3 (zh)
TR (1) TR200103286T2 (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006077821A1 (ja) * 2005-01-19 2006-07-27 Dainippon Sumitomo Pharma Co., Ltd. アルドステロン受容体調節剤としての芳香族スルホン化合物
JP2007534767A (ja) * 2004-04-27 2007-11-29 ワイス シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1998014436A1 (en) * 1996-10-02 1998-04-09 Dupont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
DE69531998T2 (de) * 1994-12-22 2004-07-22 Ligand Pharmaceuticals, Inc., San Diego Steroidrezeptor-modulator verbindungen und methoden

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1998014436A1 (en) * 1996-10-02 1998-04-09 Dupont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007534767A (ja) * 2004-04-27 2007-11-29 ワイス シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
WO2006077821A1 (ja) * 2005-01-19 2006-07-27 Dainippon Sumitomo Pharma Co., Ltd. アルドステロン受容体調節剤としての芳香族スルホン化合物
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
EP2210880A4 (en) * 2007-10-05 2012-03-07 Msd Kk BENZOXAZINONE DERIVATIVE
US8314094B2 (en) 2007-10-05 2012-11-20 Msd K.K Benzoxazinone derivative

Also Published As

Publication number Publication date
CN1145618C (zh) 2004-04-14
EA004512B1 (ru) 2004-04-29
NO321361B1 (no) 2006-05-02
TR200103286T2 (tr) 2002-07-22
KR20010114250A (ko) 2001-12-31
NZ515355A (en) 2004-02-27
NO20015378L (no) 2002-01-03
PL351127A1 (en) 2003-03-24
SG114650A1 (en) 2005-09-28
IL146280A0 (en) 2002-07-25
CA2371726A1 (en) 2000-11-09
HUP0201609A2 (en) 2002-08-28
HUP0201609A3 (en) 2002-12-28
EA200101176A1 (ru) 2002-04-25
CN1349517A (zh) 2002-05-15
SK15912001A3 (sk) 2002-06-04
NO20015378D0 (no) 2001-11-02
CZ20013951A3 (cs) 2002-05-15
BR0010213A (pt) 2002-02-19
BG106079A (en) 2002-05-31
MXPA01011286A (es) 2003-07-14
AU4688600A (en) 2000-11-17
AU766428B2 (en) 2003-10-16
EP1173426A1 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
US6509334B1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
US6436929B1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
JP5523430B2 (ja) プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体
US6444668B1 (en) Combination regimens using progesterone receptor modulators
JP2002543155A (ja) 抗プロゲスチン及びプロゲスチンを含有する避妊組成物
JP2002543193A (ja) プロゲステロン受容体モジュレーターとしてのシクロカルバメート誘導体
JP2003524626A (ja) プロゲステロンレセプタモジュレーターとしてのキナゾリノンおよびベンゾキサジン誘導体

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20061017

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070427

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070427

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100928

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110308